Edwards Lifesciences Corp (EW) stock
EWNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3057% above fair value
$105.80−0.01 (-0.01%)
Close on Nov 12, 2026Market cap $60.98BP/E 59.8Yield –
Edwards Lifesciences gross margin
Gross margin is gross profit as a percentage of revenue.
Edwards Lifesciences's gross margin for the twelve months ending Sep 30, 2026 was 78.0%. For fiscal 2025 it was 78.0%, against 79.5% the year before. The highest annual figure on record is 83.8% in fiscal 2022.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 78.0% | −1.4 |
| FY2024 | Dec 31, 2024 | 79.5% | −1.0 |
| FY2023 | Dec 31, 2023 | 80.5% | −3.3 |
| FY2022 | Dec 31, 2022 | 83.8% | +7.7 |
| FY2021 | Dec 31, 2021 | 76.1% | +0.8 |
| FY2020 | Dec 31, 2020 | 75.4% | +1.0 |
| FY2019 | Dec 31, 2019 | 74.4% | −0.4 |
| FY2018 | Dec 31, 2018 | 74.8% | +0.2 |
| FY2017 | Dec 31, 2017 | 74.5% | +1.4 |
| FY2016 | Dec 31, 2016 | 73.1% | −2.2 |
| FY2015 | Dec 31, 2015 | 75.2% | +2.2 |
| FY2014 | Dec 31, 2014 | 73.1% | −1.7 |
| FY2013 | Dec 31, 2013 | 74.7% | +0.6 |
| FY2012 | Dec 31, 2012 | 74.2% | +3.3 |
| FY2011 | Dec 31, 2011 | 70.8% | −1.0 |
| FY2010 | Dec 31, 2010 | 71.8% | +2.0 |
| FY2009 | Dec 31, 2009 | 69.8% | +3.7 |
| FY2008 | Dec 31, 2008 | 66.1% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 78.5% | +0.7 |
| Q2 FY2026 | Jun 30, 2026 | 77.5% | −0.1 |
| Q1 FY2026 | Mar 31, 2026 | 78.0% | −0.6 |
| Q4 FY2025 | Dec 31, 2025 | 78.1% | −0.8 |
| Q3 FY2025 | Sep 30, 2025 | 77.8% | −2.8 |
| Q2 FY2025 | Jun 30, 2025 | 77.5% | −2.4 |
| Q1 FY2025 | Mar 31, 2025 | 78.7% | +0.2 |
| Q4 FY2024 | Dec 31, 2024 | 78.9% | −1.3 |
| Q3 FY2024 | Sep 30, 2024 | 80.6% | +0.7 |
| Q2 FY2024 | Jun 30, 2024 | 79.9% | −0.7 |
| Q1 FY2024 | Mar 31, 2024 | 78.4% | −2.8 |
| Q4 FY2023 | Dec 31, 2023 | 80.2% | −42.8 |
| Q3 FY2023 | Sep 30, 2023 | 79.8% | −0.9 |
| Q2 FY2023 | Jun 30, 2023 | 80.6% | +0.2 |
| Q1 FY2023 | Mar 31, 2023 | 81.2% | +3.6 |
| Q4 FY2022 | Dec 31, 2022 | 123.0% | +46.3 |
| Q3 FY2022 | Sep 30, 2022 | 80.8% | +4.5 |
| Q2 FY2022 | Jun 30, 2022 | 80.4% | +4.7 |
| Q1 FY2022 | Mar 31, 2022 | 77.7% | +1.8 |
| Q4 FY2021 | Dec 31, 2021 | 76.7% | +1.6 |
| Q3 FY2021 | Sep 30, 2021 | 76.2% | +0.8 |
| Q2 FY2021 | Jun 30, 2021 | 75.7% | +1.5 |
| Q1 FY2021 | Mar 31, 2021 | 75.9% | −0.6 |
| Q4 FY2020 | Dec 31, 2020 | 75.1% | −0.5 |
| Q3 FY2020 | Sep 30, 2020 | 75.4% | +2.1 |
| Q2 FY2020 | Jun 30, 2020 | 74.2% | +2.2 |
| Q1 FY2020 | Mar 31, 2020 | 76.5% | −0.1 |
| Q4 FY2019 | Dec 31, 2019 | 75.6% | −0.4 |
| Q3 FY2019 | Sep 30, 2019 | 73.3% | −1.9 |
| Q2 FY2019 | Jun 30, 2019 | 72.0% | −1.9 |
| Q1 FY2019 | Mar 31, 2019 | 76.7% | +2.8 |
| Q4 FY2018 | Dec 31, 2018 | 76.0% | +2.5 |
| Q3 FY2018 | Sep 30, 2018 | 75.2% | +1.2 |
| Q2 FY2018 | Jun 30, 2018 | 73.9% | −1.0 |
| Q1 FY2018 | Mar 31, 2018 | 73.9% | −1.7 |
| Q4 FY2017 | Dec 31, 2017 | 73.5% | +1.3 |
| Q3 FY2017 | Sep 30, 2017 | 74.0% | – |
| Q2 FY2017 | Jun 30, 2017 | 74.9% | – |
| Q1 FY2017 | Mar 31, 2017 | 75.6% | – |
| Q4 FY2016 | Dec 31, 2016 | 72.2% | – |
See a number that looks wrong?